• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

东盎格利亚剑桥郡北部地区的多发性硬化症

Multiple sclerosis in the north Cambridgeshire districts of East Anglia.

作者信息

Robertson N, Deans J, Fraser M, Compston D A

机构信息

University of Cambridge Neurology Unit, Addenbrooke's Hospital, UK.

出版信息

J Neurol Neurosurg Psychiatry. 1995 Jul;59(1):71-6. doi: 10.1136/jnnp.59.1.71.

DOI:10.1136/jnnp.59.1.71
PMID:7608713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1073604/
Abstract

The Cambridgeshire multiple sclerosis register was established in 1989 and initially reported a prevalence of 130/10(5) population for south and east Cambridgeshire (south Cambs). This survey has now been extended to the northern county districts where there were 449 patients with multiple sclerosis in population of 378,959 on 1 July 1993 (118/10(5); 95% confidence interval (95% CI) 108-130). Four hundred and four had either definite or probable disease (107/10(5); 95% CI: 98-118). This matches the highest figures in the series of seven epidemiological surveys carried out in southern England over the past decade. Comparison with these and other studies indicates that no latitudinal gradient of disease is found in southern England despite spanning four degrees of latitude.

摘要

剑桥郡多发性硬化症登记处成立于1989年,最初报告剑桥郡南部和东部(南剑桥郡)的患病率为130/10⁵人口。这项调查现已扩展到北部县区,1993年7月1日,在378,959人的人口中有449例多发性硬化症患者(118/10⁵;95%置信区间(95%CI)108 - 130)。404例患有确诊或可能的疾病(107/10⁵;95%CI:98 - 118)。这与过去十年在英格兰南部进行的七次流行病学调查系列中的最高数字相符。与这些研究及其他研究的比较表明,尽管跨越了四个纬度,但在英格兰南部未发现疾病的纬度梯度。

相似文献

1
Multiple sclerosis in the north Cambridgeshire districts of East Anglia.东盎格利亚剑桥郡北部地区的多发性硬化症
J Neurol Neurosurg Psychiatry. 1995 Jul;59(1):71-6. doi: 10.1136/jnnp.59.1.71.
2
Multiple sclerosis in the Cambridge health district of east Anglia.东安格利亚剑桥健康区的多发性硬化症
J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):877-82. doi: 10.1136/jnnp.55.10.877.
3
Multiple sclerosis in south Cambridgeshire: incidence and prevalence based on a district register.剑桥郡南部的多发性硬化症:基于地区登记册的发病率和患病率
J Epidemiol Community Health. 1996 Jun;50(3):274-9. doi: 10.1136/jech.50.3.274.
4
Estimating the prevalence of multiple sclerosis in the United Kingdom by using capture-recapture methodology.运用捕获-再捕获法估算英国多发性硬化症的患病率。
Am J Epidemiol. 1999 Jun 1;149(11):1016-24. doi: 10.1093/oxfordjournals.aje.a009746.
5
The prevalence of multiple sclerosis in south east Wales.威尔士东南部多发性硬化症的患病率。
J Neurol Neurosurg Psychiatry. 1988 Dec;51(12):1520-4. doi: 10.1136/jnnp.51.12.1520.
6
Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity.爱尔兰多发性硬化症患病率的纬度变化:遗传多样性的影响
J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):572-6. doi: 10.1136/jnnp.2003.012666.
7
The epidemiology of multiple sclerosis in Devon: a comparison of the new and old classification criteria.德文郡多发性硬化症的流行病学:新旧分类标准的比较
J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):56-60.
8
Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.爱尔兰共和国多发性硬化症的发病率:一项前瞻性基于人群的研究。
Mult Scler Relat Disord. 2017 Apr;13:75-80. doi: 10.1016/j.msard.2017.02.010. Epub 2017 Feb 14.
9
Prevalence of multiple sclerosis in a south London borough.伦敦南部一个行政区的多发性硬化症患病率。
Br Med J (Clin Res Ed). 1986 Jul 26;293(6541):237-9. doi: 10.1136/bmj.293.6541.237.
10
Multiple sclerosis in the north Cambridgeshire districts of East Anglia.东盎格利亚剑桥郡北部地区的多发性硬化症
J Neurol Neurosurg Psychiatry. 1996 Jul;61(1):121. doi: 10.1136/jnnp.61.1.121.

引用本文的文献

1
Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil.系统文献回顾和荟萃分析美国、欧洲、加拿大、澳大利亚和巴西的继发进展性多发性硬化症的患病率。
BMC Neurol. 2022 Aug 17;22(1):301. doi: 10.1186/s12883-022-02820-0.
2
Using the Fatigue Severity Scale to inform healthcare decision-making in multiple sclerosis: mapping to three quality-adjusted life-year measures (EQ-5D-3L, SF-6D, MSIS-8D).使用疲劳严重程度量表为多发性硬化症的医疗决策提供信息:与三种质量调整生命年衡量指标(EQ-5D-3L、SF-6D、MSIS-8D)相关联。
Health Qual Life Outcomes. 2019 Aug 5;17(1):136. doi: 10.1186/s12955-019-1205-y.
3
Multiple sclerosis: relapses, resource use, and costs.多发性硬化症:复发、资源利用及成本
Eur J Health Econ. 2016 Sep;17(7):875-84. doi: 10.1007/s10198-015-0728-3. Epub 2015 Oct 5.
4
Incidence and prevalence of multiple sclerosis in Europe: a systematic review.欧洲多发性硬化症的发病率和患病率:系统评价。
BMC Neurol. 2013 Sep 26;13:128. doi: 10.1186/1471-2377-13-128.
5
Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.地磁扰动可能是多发性硬化症的环境风险因素:24 个国家 111 个地点的生态学研究。
BMC Neurol. 2012 Sep 24;12:100. doi: 10.1186/1471-2377-12-100.
6
Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity.爱尔兰多发性硬化症患病率的纬度变化:遗传多样性的影响
J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):572-6. doi: 10.1136/jnnp.2003.012666.
7
The epidemiology of multiple sclerosis in Devon: a comparison of the new and old classification criteria.德文郡多发性硬化症的流行病学:新旧分类标准的比较
J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):56-60.
8
Multiple sclerosis in Northern Ireland: a historical and global perspective.北爱尔兰的多发性硬化症:历史与全球视角
Ulster Med J. 2000 Nov;69(2):97-105.
9
The prevalence of multiple sclerosis in the Leeds Health Authority.利兹卫生局辖区内多发性硬化症的患病率。
J Neurol Neurosurg Psychiatry. 1998 May;64(5):605-10. doi: 10.1136/jnnp.64.5.605.

本文引用的文献

1
A prevalence survey of multiple sclerosis in Sussex.苏塞克斯郡多发性硬化症患病率调查。
J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):27-30. doi: 10.1136/jnnp.58.1.27.
2
Multiple sclerosis in island populations: prevalence in the Bailiwicks of Guernsey and Jersey.岛屿人群中的多发性硬化症:根西岛和泽西岛辖区的患病率
J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):22-6. doi: 10.1136/jnnp.58.1.22.
3
Surveying multiple sclerosis in the United Kingdom.英国多发性硬化症调查
J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):2-6. doi: 10.1136/jnnp.58.1.2.
4
Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology.奥克尼群岛和设得兰群岛的多发性硬化症。I:流行病学、临床因素及方法学
J Epidemiol Community Health. 1980 Dec;34(4):229-39. doi: 10.1136/jech.34.4.229.
5
A further prevalence study of multiple sclerosis in north-east Scotland.苏格兰东北部多发性硬化症的进一步患病率研究。
J Neurol Neurosurg Psychiatry. 1980 Apr;43(4):310-5. doi: 10.1136/jnnp.43.4.310.
6
New diagnostic criteria for multiple sclerosis: guidelines for research protocols.多发性硬化症的新诊断标准:研究方案指南。
Ann Neurol. 1983 Mar;13(3):227-31. doi: 10.1002/ana.410130302.
7
The chief scientist reports ... multiple sclerosis in North East Scotland.
Health Bull (Edinb). 1984 May;42(3):151-6.
8
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).评估多发性硬化症的神经功能损伤:扩展残疾状态量表(EDSS)
Neurology. 1983 Nov;33(11):1444-52. doi: 10.1212/wnl.33.11.1444.
9
Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa.南非出生的白人以及移民到南非的白人中多发性硬化症的年发病率、患病率和死亡率。
Br Med J. 1967 Jun 17;2(5554):724-30. doi: 10.1136/bmj.2.5554.724.
10
Declining incidence of multiple sclerosis in the Orkney Islands.
Neurology. 1985 Apr;35(4):545-51. doi: 10.1212/wnl.35.4.545.